Don’t Miss a Beat on A-fib: How to Make the Right Plans for Individual PatientsThis practical, data-fueled talk from Edward P. Gerstenfeld, MD, MS, FACC, chief of the UCSF Cardiac Electrophysiology and Arrhythmia Service, will help PCPs better understand how to assess stroke risk; make treatment decisions...
Learning and Lowering Cardiovascular Risk: Effective, Efficient StrategiesThis data-driven presentation from cardiologist Eveline Stock, MD, will give you a better grasp on how to identify an at-risk patient.
Common Vascular Conditions: Simple Screening Rules and Better Treatment TacticsVascular surgeon Shant Vartanian, MD, presents an update on understanding and managing abdominal aortic aneurysms and peripheral artery disease – prevalent age-linked disorders with significant morbidity and mortality.
Keep Diabetic Patients on Their Feet: Keys to Identifying Limb-Threatening IssuesIn a country where more than 9% of adults have diabetes, Alexander Reyzelman, DPM, discusses the implications for those who also have peripheral vascular disease.
Getting to the Heart of COVID: Do Infections or Vaccines Cause Cardiac Harm?Cardiologist Clifton Watt, MD, offers new insights on the pathogenesis of heart problems resulting from COVID; breaks down the evidence on whether novel treatments – neutralizing antibodies and antivirals – have therapeutic or preventive value; then presents a risk-benefit analysis for the available vaccines, incorporating new data.
Minimally Invasive Heart Repair: The Future Is NowThree UCSF specialists shine a light on the rapidly evolving world of minimally invasive heart surgery, giving the evidence on risks and outcomes.
What’s Hidden in the Female Heart: Keys to Identifying Women at Risk for Cardiovascular DiseaseCardiologist Jie Yang, MD, breaks down the evidence by age group and offers actionable steps for helping patients lower their risk.
Don’t Lose Heart: Responding to Cardiovascular Effects of the PandemicCardiologist and echocardiographer Nisha I. Parikh, MD, MPH, discusses acute and chronic cardiovascular issues in COVID patients, and how imaging can help with early diagnosis and monitoring treatment response. She also looks at the consequences of delayed care for heart events due to patients’ pandemic-related anxiety.
Reshaping Care for Heart Failure: The Promise of New Drugs and DevicesHeart failure is increasingly prevalent and continues to have a high mortality rate, yet the future isn’t bleak. Cardiologist Liviu Klein, MD, MS, director of the UCSF Mechanical Circulatory Support Program, presents cutting-edge therapeutic options, including drugs, surgical implants and advanced monitoring systems.
COVID-19 Consequences: Is the Ticker a Ticking Time Bomb?Cardiologist Clifton Watt, MD, explores what’s now known about the SARS-CoV-2 variants as well as COVID-related multisystem inflammatory disorders, explains COVID’s potential for residual effects on the heart, and offers help with identifying COVID “long haulers.” Bonus: update on outpatient therapeutics.
Comorbidities and COVID: Care for Patients With Heart Disease and Other ConditionsBreaking down the latest stats, cardiologist Clifton Watt, MD, sheds light on which chronic conditions raise the risk of serious consequences from COVID-19 infection.
Keep Them on Their Feet: Vigilant Diabetic Care Saves LimbsIn response to rising rates of diabetes and related amputations, the co-directors of UCSF’s Center for Limb Preservation – which has a limb salvage rate of 92 percent – present a quick guide to detecting amputation risk. They include COVID-specific advice to prevent delays in diagnosis and referral.
A Common Threat to Life and Limb: Detect and Manage Peripheral Artery DiseaseMichael S. Conte, MD, UCSF’s chief of vascular surgery, discusses the growing problem of PAD, subtleties of PAD signs, useful testing techniques, which patients to treat, therapeutic options, and how to educate your patients – especially diabetics – to safeguard their health.
Chronic Venous Insufficiency: Caring for a Common and Disabling ConditionProper classification and appropriate treatment of CVI will relieve pain and improve quality of life. Interventional radiologist Alexander Lam, MD, presents current guidelines and therapeutic options.
Introduction to Strain Imaging EchocardiographyClifton Watt, MD, explains that echocardiography is one of the most common noninvasive tools used in cardiology to date, while strain imaging is a supplementary way to assess myocardial function.
Using VADs in Advanced Heart Failure: Caring for a Growing PopulationWith heart failure’s prevalence and poor prognosis, it’s important to understand the difference VADs can make. Cardiologist Dr. Liviu Klein discusses the latest devices, implantation techniques and monitoring methods, as well as outcomes and best candidates.
Optimize Spinal Surgery Outcomes Through TeamworkVascular surgeon Dr. Charles Eichler discusses UCSF’s success with including vascular surgeons in lumbar fusion procedures and finding the least invasive approach for each patient.
UCSF 2019 Heart & Vascular SymposiumExcellence in heart and vascular services
Limb Preservation for Patients with Diabetic Foot UlcersMichael S. Conte, MD, provides an overview of the various noncardiac and extracranial blood vessel conditions treated by the Division of Vascular & Endovascular Surgery.
Minimally-Invasive Mitral Valve SurgeryTobias Deuse, MD, discusses the advantages of minimally invasive approaches for the treatment of mitral valve insufficiency.
Redefining Sudden Cardiac DeathZian H. Tseng, MD, discusses the conclusions of the UCSF Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death (POST SCD) Study.
Transcatheter Heart Valve Therapies: Transformative Technology in Health CareVaikom Mahadevan, MD, discusses the history of transcatheter valve implants and their advantages, including less risk, less blood loss and shorter hospital stays.
Hypertrophic Cardiomyopathy: Mostly Benign, Sometimes LethalTheodore Abraham, MD, discusses hypertrophic cardiomyopathy, a common inherited heart disease that is usually benign, but can be fatal in up to 10 percent of cases.
Percutaneous Treatment of Cardiac Valvular Disease: Part 1V.S. Mahadevan, MD, FACC, FSCAI, FRCP, provides an overview of percutaneous treatment of cardiac valvular disease, particularly where surgery is not an option. Dr. Mahadevan concentrates on the pulmonic and aortic valve and the options available...